Board Members and Executives

The Board Members and Executives at Enterin are responsible for overseeing the strategic direction, financial health, and operational efficiency of the company. They guide the development and commercialization of novel drugs targeting the gut-brain axis in neurodegenerative diseases, ensuring regulatory compliance and fostering investor relations to support long-term growth.